» Articles » PMID: 24625722

Sialyltransferase Activity and Atherosclerosis

Overview
Journal Circ Res
Date 2014 Mar 15
PMID 24625722
Citations 6
Authors
Affiliations
Soon will be listed here.
Citing Articles

Sialic acid in the regulation of blood cell production, differentiation and turnover.

Irons E, Gc S, Lau J Immunology. 2024; 172(4):517-532.

PMID: 38503445 PMC: 11223974. DOI: 10.1111/imm.13780.


Lipoprotein sialylation in atherosclerosis: Lessons from mice.

Yu L, Peng J, Mineo C Front Endocrinol (Lausanne). 2022; 13:953165.

PMID: 36157440 PMC: 9498574. DOI: 10.3389/fendo.2022.953165.


Sialic acid metabolism as a potential therapeutic target of atherosclerosis.

Zhang C, Chen J, Liu Y, Xu D Lipids Health Dis. 2019; 18(1):173.

PMID: 31521172 PMC: 6745061. DOI: 10.1186/s12944-019-1113-5.


Recombinant Sialyltransferase Infusion Mitigates Infection-Driven Acute Lung Inflammation.

Nasirikenari M, Lugade A, Neelamegham S, Gao Z, Moremen K, Bogner P Front Immunol. 2019; 10:48.

PMID: 30778346 PMC: 6369197. DOI: 10.3389/fimmu.2019.00048.


The blood-borne sialyltransferase ST6Gal-1 is a negative systemic regulator of granulopoiesis.

Dougher C, Buffone Jr A, Nemeth M, Nasirikenari M, Irons E, Bogner P J Leukoc Biol. 2017; 102(2):507-516.

PMID: 28550122 PMC: 5505748. DOI: 10.1189/jlb.3A1216-538RR.